COOPER, CHRISTOPHER B.,HUANG, HAIHONG,ZHANG, DONGFENG,FOTOUHI, NADER,KANEKO, TAKUSHI
申请号：
CA2990260
公开号：
CA2990260A1
申请日:
2016.07.15
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The present invention relates to novel oxazolidinones (Formula I): or a pharmaceutically acceptable salt having ring A characterized by N-containing monocyclic, bicyclic or spirocyclic substituents, to their preparation, and to their use as drugs for treating Mycobacterium tuberculosis and other microbial infections, either alone or in combination with other anti-infective treatments.
